News
June 2024
Klinrisk and ProKidney partnership represented in ProKidney’s June 2024 company updates.
ProKidney Partnership
March 14, 2024
Revolutionizing Chronic Kidney Disease Management on World Kidney Day
Today, as the world marks World Kidney Day, Lifelabs, in exclusive partnership with Klinrisk, proudly announces a groundbreaking advancement in chronic kidney disease (CKD) screening and management: the inclusion of the Klinrisk Score as a validated…
Lifelabs, Canada’s leading diagnostic testing services and recognized as the most trusted brand in health diagnostic services by Canadians, proudly announces an exclusive partnership with Klinrisk, a Canadian AI-based medical device company focused on improving early detection and treatment of chronic kidney disease (CKD) through the groundbreaking Klinrisk Score.
LifeLabs and Klinrisk Join Forces to Revolutionize Chronic Kidney Disease Care
January 11, 2024
Novel AI-Driven Model Validated to Predict Risk of Chronic Kidney Disease Progression in Large U.S. Study
November 4, 2023
Boehringer Ingelheim and Carelon Research have conducted a validation study of the Klinrisk model, a machine-learning tool developed to predict the risk of chronic kidney disease (CKD) progression at all stages of the disease. Using data from a diverse population of over 4 million U.S. adults, the model was more than 80% accurate in predicting CKD progression…
NKF’s Innovation Fund Invests in Klinrisk to Revolutionize Chronic Kidney Disease Care
June 12, 2023
The National Kidney Foundation (NKF) is proud to announce its latest investment through NKF’s Innovation Fund in Klinrisk, an artificial intelligence-based medical device company. Klinrisk is dedicated to transforming the early identification and management of high-risk chronic kidney disease (CKD) through accurate clinical risk prediction…